DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dexamethasone (Dexamethasone) - Pyrexia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pyrexia (163)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 163   Next >>

Possible Dexamethasone side effects in female

Reported by a physician from France on 2012-08-21

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.82 milligram daily;
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Dexamethasone
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Rituximab
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Treanda
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Other drugs received by patient: Pegfilgrastim



Possible Dexamethasone side effects in female

Reported by a physician from France on 2012-08-21

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.82 milligram daily;
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Dexamethasone
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Rituximab
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Treanda
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Other drugs received by patient: Pegfilgrastim



Possible Dexamethasone side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16

Patient: female, weighing 87.8 kg (193.2 pounds)

Reactions: Neuropathy Peripheral, Upper Respiratory Tract Infection, Urinary Tract Infection, Pleural Effusion, Pyrexia, Leukocytosis, Sinusitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Mantle Cell Lymphoma

Cytarabine
    Dosage: 1.87 g, cyclic
    Indication: Mantle Cell Lymphoma

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Mantle Cell Lymphoma

Doxorubicin Hydrochloride
    Dosage: 50 mg/m2, unk
    Indication: Mantle Cell Lymphoma

Mesna
    Dosage: 600 mg/m2, unk
    Indication: Mantle Cell Lymphoma

Methotrexate
    Indication: Mantle Cell Lymphoma

Rituximab
    Dosage: 1 mg/m2, cyclic
    Indication: Mantle Cell Lymphoma

Velcade
    Dosage: 0.7 mg/m2, cyclic
    Start date: 2012-03-19

Velcade
    Dosage: 2.77 mg, cyclic
    Indication: Mantle Cell Lymphoma
    Start date: 2011-12-31

Velcade
    Dosage: 0.7 mg/m2, cyclic

Velcade
    Dosage: 0.7 mg/m2, cyclic
    Start date: 2012-02-26

Vincristine
    Dosage: 2 mg, cyclic
    Indication: Mantle Cell Lymphoma

Other drugs received by patient: Sennosides A+B; Nystatin; Diphenhydramine Hydrochloride; Neupogen; Fluconazole; Zofran; Valtrex; Sodium Chloride; Meperidine HCL; Potassium Chloride; Leucovorin Calcium; Zofran; Sodium Chloride; Sodium Chloride; Sodium Chloride; Heparin; Leucovorin Calcium; Allopurinol; Lovenox; Morphine; Senokot; Cipro / 00042702 /; Lovenox; Prednisolone Acetate; Stomatologicals, Mouth Preparations; Tramadol; Sodium Bicarbonate



Possible Dexamethasone side effects in male

Reported by a physician from United States on 2012-08-15

Patient: male

Reactions: Streptococcal Bacteraemia, Otitis Media, Neutropenia, Pyrexia, Sinusitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bms833923
    Dosage: 90 mg
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-05-20

Dexamethasone
    Dosage: 40 mg
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-04-01
    End date: 2011-04-05

Dexamethasone
    Administration route: Oral
    Start date: 2011-04-01

Lenalidomide
    Dosage: 10 mg
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-04-01
    End date: 2011-04-05

Lenalidomide
    Administration route: Oral
    Start date: 2011-04-01

Other drugs received by patient: Aspirin; Neurontin; Multi-Vitamins; Senokot; Clonazepam; Ativan; Calcium; Neurontin; Calcium and Vitamin D; Magnesium; Clonopin



Possible Dexamethasone side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Oophoritis, Pancytopenia, Cytomegalovirus Infection, Pyrexia, Pneumonia Cytomegaloviral

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Hodgkin's Disease

Carboplatin
    Indication: Hodgkin's Disease

Cisplatin
    Indication: Hodgkin's Disease

Cytarabine
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Dexamethasone
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Gemcitabine Hydrochloride
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Rituximab
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vinorelbine
    Indication: Hodgkin's Disease

Other drugs received by patient: Radiotherapy



Possible Dexamethasone side effects in 29 year old female

Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14

Patient: 29 year old female

Reactions: Histiocytosis Haematophagic, Oophoritis, Cytomegalovirus Infection, Pancytopenia, Pyrexia, Pneumonia Cytomegaloviral

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Bleomycin Sulfate
    Indication: Hodgkin's Disease

Carboplatin
    Indication: Hodgkin's Disease

Cisplatin
    Indication: Hodgkin's Disease

Cytarabine
    Indication: Hodgkin's Disease

Dacarbazine
    Indication: Hodgkin's Disease

Dexamethasone
    Indication: Hodgkin's Disease

Doxorubicin Hydrochloride
    Indication: Hodgkin's Disease

Etoposide
    Indication: Hodgkin's Disease

Gemcitabine Hydrochloride
    Indication: Hodgkin's Disease

Ifosfamide
    Indication: Hodgkin's Disease

Rituximab
    Indication: Hodgkin's Disease

Vinblastine Sulfate
    Indication: Hodgkin's Disease

Vinorelbine
    Indication: Hodgkin's Disease

Other drugs received by patient: Radiotherapy



Possible Dexamethasone side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-09

Patient: male, weighing 80.0 kg (176.0 pounds)

Reactions: Systemic Inflammatory Response Syndrome, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Start date: 2011-08-09

Bortezomib
    End date: 2012-02-16

Dexamethasone
    Start date: 2011-08-09

Dexamethasone
    End date: 2012-02-17

Revlimid
    Administration route: Oral
    Start date: 2011-08-09

Revlimid
    Administration route: Oral
    End date: 2012-02-09

Other drugs received by patient: Valacyclovir Hydrochloride; Bactrim



Possible Dexamethasone side effects in 65 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-06

Patient: 65 year old female, weighing 62.0 kg (136.4 pounds)

Reactions: Hypersensitivity, Pain, Anaemia, Rash, Multiple Myeloma, Pyrexia, Constipation, Fatigue, Granulocytopenia, Thrombocytopenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Dexamethasone
    Indication: Myeloma Recurrence
    Start date: 2009-10-01
    End date: 2009-10-21

Revlimid
    Administration route: Oral
    Indication: Myeloma Recurrence
    Start date: 2009-10-01
    End date: 2009-10-21

Other drugs received by patient: Filgrastim; Levofloxacin; Levofloxacin; Filgrastim; Filgrastim; Filgrastim; Ribodronat; Heparin



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient:

Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Elotuzumab
    Dosage: 5, 10 and 20 mg/kg
    Indication: Multiple Myeloma

Elotuzumab
    Dosage: 5, 10 and 20 mg/kg

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient: female, weighing 46.0 kg (101.2 pounds)

Reactions: Back Pain, Urinary Incontinence, Muscular Weakness, Pyrexia, Disorientation, Feeling Cold

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 32 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-03
    End date: 2012-03-17

Velcade
    Dosage: 1.5 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2012-03-04
    End date: 2012-03-23

Other drugs received by patient: Losartan Potassium; Omeprazole; Miralax; Reglan; Senna-S / 01035001 /; Methadone HCL; Zofran; Valtrex; Dilaudid



Possible Dexamethasone side effects in

Reported by a physician from Italy on 2012-08-03

Patient:

Reactions: Pyrexia, Constipation, Disease Progression, Liver Disorder, Herpes Zoster, Cardiac Disorder, Death, Neuropathy Peripheral, Oedema, Thrombocytopenia, Hyperglycaemia, Toxicity To Various Agents, Rash, Gastrointestinal Disorder, Pancreatitis, Deep Vein Thrombosis, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3 milligram/sq. meter

Bortezomib
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma

Bortezomib
    Dosage: 1 milligram/sq. meter

Bortezomib
    Dosage: .7 milligram/sq. meter

Dexamethasone
    Dosage: 40 milligram

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram

Dexamethasone
    Dosage: 40 milligram

Dexamethasone
    Dosage: 40 milligram

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral

Thalidomide
    Dosage: 200 milligram
    Administration route: Oral

Thalidomide
    Dosage: 50 milligram
    Administration route: Oral

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral

Thalidomide
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Acyclovir; Melphalan Hydrochloride; Neupogen; Neupogen; Cyclophosphamide



Possible Dexamethasone side effects in female

Reported by a physician from Belgium on 2012-08-03

Patient: female, weighing 62.0 kg (136.4 pounds)

Reactions: Anaemia, Febrile Neutropenia, Pyrexia, Lung Squamous Cell Carcinoma Stage Unspecified, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Administration route: Oral
    Start date: 2011-06-24
    End date: 2011-07-20

Dexamethasone
    Start date: 2012-07-04

Dexamethasone
    Administration route: Oral
    Start date: 2012-04-26

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Start date: 2012-05-31

Dexamethasone
    Start date: 2012-07-02

Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-05

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    End date: 2012-06-27

Dexamethasone
    Start date: 2012-07-03

Revlimid
    Administration route: Oral
    Start date: 2011-02-03
    End date: 2011-04-20

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-04-26

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-06-24
    End date: 2011-12-28

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-05-30
    End date: 2012-06-27

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2012-02-02

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-05-31

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-05

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-28
    End date: 2011-06-16

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2012-01-05
    End date: 2012-01-25

Other drugs received by patient: Aspirin; Cranberry Extract; RED Blood Cells; Paracodeine; Omeprazole; Pantoprazole; Flexium; Meropenem; Symbicort; Flexium; Cetavlex; Polyethylene Glycol; Sodium Chloride; Duovent; Aspirin; Bisoprolol Fumarate; R Calm Creme; RED Blood Cells; Platelets; Platelets; Whole Blood; Paracodeine



Possible Dexamethasone side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-03

Patient: 60 year old female

Reactions: Vascular Occlusion, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-18
    End date: 2012-05-25

Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-18
    End date: 2012-05-21

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-18
    End date: 2012-05-26



Possible Dexamethasone side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-31

Patient: female, weighing 29.9 kg (65.8 pounds)

Reactions: Sphingomonas Paucimobilis Infection, Contusion, Clostridium Test Positive, Tachycardia, Rectal Haemorrhage, Pyrexia, Resuscitation, Heart Rate Decreased, Balance Disorder, Abdominal Distension, Pain in JAW, Lethargy

Adverse event resulted in: death

Drug(s) suspected as cause:
Cytarabine
    Dosage: 70 mg
    End date: 2012-07-12

Daunorubicin HCL
    Dosage: 52 mg
    End date: 2012-07-20

Dexamethasone
    Dosage: 132 mg
    End date: 2012-07-23

Methotrexate
    Dosage: 12 mg
    End date: 2012-07-20

PEG-L-Asparaginase (Pegaspargase, Oncospar)
    Dosage: 2680 mg
    End date: 2012-07-16

Vincristine Sulfate
    Dosage: 3.1 mg
    End date: 2012-07-20



Possible Dexamethasone side effects in 78 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient: 78 year old female, weighing 46.0 kg (101.2 pounds)

Reactions: Back Pain, Urinary Incontinence, Muscular Weakness, Disorientation, Pyrexia, Feeling Cold

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 32 mg, cyclic
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-03
    End date: 2012-03-17

Velcade
    Dosage: 1.5 mg, cyclic
    Indication: Multiple Myeloma
    Start date: 2012-03-04
    End date: 2012-03-23

Other drugs received by patient: Zofran; Losartan Potassium; Miralax; Dilaudid; Methadone HCL; Reglan; Senna-S / 01035001 /; Omeprazole; Valtrex



Possible Dexamethasone side effects in female

Reported by a physician from Belgium on 2012-07-30

Patient: female, weighing 62.6 kg (137.7 pounds)

Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased, Pyrexia, Lung Squamous Cell Carcinoma Stage Unspecified

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Start date: 2012-07-02

Dexamethasone
    Start date: 2012-07-03

Dexamethasone
    Administration route: Oral
    Start date: 2011-06-24
    End date: 2011-07-20

Dexamethasone
    Administration route: Oral
    Start date: 2012-04-26

Dexamethasone
    Start date: 2012-07-04

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Start date: 2012-05-31

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    End date: 2012-06-27

Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-05

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-28
    End date: 2011-06-16

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2012-01-05
    End date: 2012-01-25

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2012-02-02

Revlimid
    Administration route: Oral
    Start date: 2011-02-03
    End date: 2011-04-20

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-06-24
    End date: 2011-12-28

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-04-26

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-05-31

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-05-30
    End date: 2012-06-27

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-05

Other drugs received by patient: R Calm Creme; RED Blood Cells; Cetavlex; Flexium; Platelets; Polyethylene Glycol; Aspirin; Meropenem; Bisoprolol Fumarate; Flexium; Sodium Chloride; Symbicort; Cranberry Extract; Pantoprazole



Possible Dexamethasone side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-30

Patient: male, weighing 15.6 kg (34.3 pounds)

Reactions: Neutropenia, Pyrexia

Drug(s) suspected as cause:
Daunorubicin HCL
    Dosage: 47.25 mg
    End date: 2012-07-26

Dexamethasone
    Dosage: 42 mg
    End date: 2012-07-25

Methotrexate
    Dosage: 24 mg
    End date: 2012-07-24

PEG-L-Asparaginase (Pegaspargase, Oncospar)
    Dosage: 1597.5 mg
    End date: 2012-07-16

Vincristine Sulfate
    Dosage: 2.85 mg
    End date: 2012-07-26



Possible Dexamethasone side effects in

Reported by a physician from Netherlands on 2012-07-30

Patient:

Reactions: Diarrhoea, Pyrexia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-11

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-15

Velcade
    Dosage: 2.6 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-14



Possible Dexamethasone side effects in

Reported by a physician from Israel on 2012-07-28

Patient:

Reactions: Febrile Neutropenia, Hyponatraemia, Pyrexia, Hypokalaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Aprepitant
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded Aprepitant
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded Aprepitant
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded Aprepitant
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded Ondansetron HCL
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded Ondansetron HCL
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded Post Trial Therapy
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Blinded Post Trial Therapy
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded PRE Trial Therapy
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Blinded PRE Trial Therapy
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Cisplatin
    Dosage: 46.2 mg/kg, qd
    Indication: Chemotherapy
    Start date: 2012-06-18
    End date: 2012-06-18

Cytoxan
    Dosage: 172 mg, qd
    Indication: Chemotherapy
    Start date: 2012-06-19
    End date: 2012-06-20

Dexamethasone
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Dexamethasone
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Etoposide
    Dosage: 33 mg, qd
    Indication: Chemotherapy
    Start date: 2012-06-18
    End date: 2012-06-20

Ondansetron
    Administration route: Oral
    Indication: Prophylaxis of Nausea and Vomiting
    Start date: 2012-06-18
    End date: 2012-06-22

Placebo
    Administration route: Oral
    Start date: 2012-06-18
    End date: 2012-06-18

Placebo
    Administration route: Oral
    Start date: 2012-06-19
    End date: 2012-06-20

Vincristine Sulfate
    Dosage: 0.6 mg, qd
    Start date: 2012-06-24
    End date: 2012-06-24

Vincristine Sulfate
    Dosage: 0.66 mg, qd
    Start date: 2012-07-01
    End date: 2012-07-01

Vincristine Sulfate
    Dosage: 0.66 mg, qd
    Indication: Chemotherapy
    Start date: 2012-06-18
    End date: 2012-06-18

Other drugs received by patient: Dexacort (Dexamethasone Sodium Phosphate); Mesna; Resprim; Diamox



Possible Dexamethasone side effects in 40 year old female

Reported by a physician from United States on 2012-07-27

Patient: 40 year old female, weighing 69.5 kg (152.9 pounds)

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.3mgm2 cyclic
    Indication: Amyloidosis
    Start date: 2012-04-17
    End date: 2012-06-18

Dexamethasone
    Dosage: 20mg cyclic
    Indication: Amyloidosis
    Start date: 2012-04-17
    End date: 2012-05-18

Melphalan Hydrochloride
    Indication: Amyloidosis
    Start date: 2012-06-12
    End date: 2012-06-13

Other drugs received by patient: Prilosec; Prochlorperazine Maleate; Lasix; Klor-CON; Tazorac; Ativan; Duac; Imodium; Minocycline HCL; Lupron Depot; Acyclovir; Prevident



Possible Dexamethasone side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-25

Patient: male, weighing 15.5 kg (34.1 pounds)

Reactions: Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Daunorubicin HCL
    Dosage: 31 mg
    End date: 2012-07-19

Dexamethasone
    Dosage: 24 mg
    End date: 2012-07-21



Possible Dexamethasone side effects in female

Reported by a physician from France on 2012-07-25

Patient: female, weighing 45.0 kg (99.0 pounds)

Reactions: Dyspnoea, Pleural Effusion, Pyrexia, Generalised Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bortezomib
    Dosage: 1.82 milligram;
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Dexamethasone
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-02

Rituximab
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Treanda
    Indication: Mantle Cell Lymphoma
    Start date: 2012-02-01

Other drugs received by patient: Pegfilgrastim



Possible Dexamethasone side effects in male

Reported by a physician from NEW Zealand on 2012-07-24

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Confusional State, Neoplasm Malignant, Neoplasm Progression, Pyrexia, Metastases To Central Nervous System, Blood Glucose Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 4 mg, qd
    Administration route: Oral
    Start date: 2008-10-15

Zoledronoc Acid
    Dosage: 4.0mg
    Indication: Prostate Cancer
    Start date: 2008-09-27

Other drugs received by patient: Vitamin D; Calcium



Possible Dexamethasone side effects in female

Reported by a physician from Belgium on 2012-07-23

Patient: female, weighing 62.6 kg (137.7 pounds)

Reactions: Pyrexia, Lung Squamous Cell Carcinoma Stage Unspecified

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Administration route: Oral
    Start date: 2012-04-26

Dexamethasone
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-05

Dexamethasone
    Start date: 2012-07-03

Dexamethasone
    Administration route: Oral
    Start date: 2011-06-24
    End date: 2011-07-20

Dexamethasone
    Start date: 2012-07-02

Dexamethasone
    Start date: 2012-07-04

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-28
    End date: 2011-06-16

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-06-24
    End date: 2011-12-28

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-04-26

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2012-01-05
    End date: 2012-01-25

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-01-05

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2012-02-02

Revlimid
    Administration route: Oral
    Start date: 2011-02-03
    End date: 2011-04-20

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2012-05-31

Other drugs received by patient: Pantoprazole; Cranberry Extract; Aspirin; Flexium; Sodium Chloride; R Calm Creme; Flexium; Meropenem; Polyethylene Glycol; Symbicort; Platelets; Cetavlex; Bisoprolol Fumarate; RED Blood Cells



Possible Dexamethasone side effects in male

Reported by a individual with unspecified qualification from United States on 2012-07-23

Patient: male, weighing 54.0 kg (118.8 pounds)

Reactions: White Blood Cell Count Decreased, Pneumonia, Chills, Anaemia, Febrile Neutropenia, Pyrexia, Oropharyngeal Pain, Fatigue, Respiratory Failure, Tachypnoea, Cough, Oxygen Saturation Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 135 mg

Mercaptopurine
    Dosage: 8000 mg

Methotrexate
    Dosage: 270 mg



Possible Dexamethasone side effects in

Reported by a physician from France on 2012-07-19

Patient:

Reactions: Lung Disorder, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 140 mg, unk
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2011-11-15

Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2011-11-12

Velcade
    Dosage: 2.4 mg, unk
    Indication: Multiple Myeloma
    Start date: 2011-11-04
    End date: 2012-02-07

Other drugs received by patient: Calciparine; Plavix; Lercanidipine; Ezetimibe; Perindopril Erbumine; ART; Imovane; Bisoprolol Fumarate; Pantoprazole; Klipal / 01259001 /



Possible Dexamethasone side effects in female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-18

Patient: female, weighing 84.0 kg (184.8 pounds)

Reactions: Multiple Myeloma, Pyrexia, Headache

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-10-15
    End date: 2009-11-13

Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Start date: 2009-08-18

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2009-10-15
    End date: 2009-11-13

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2009-08-18

Other drugs received by patient: Omeprazole; Sulphametoxazole / Trimetoprim; Enoxaparin; Heparin Sodium; Acyclovir



Possible Dexamethasone side effects in male

Reported by a physician from Japan on 2012-07-18

Patient: male

Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Start date: 2012-01-13
    End date: 2012-02-03

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-10
    End date: 2012-01-07

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-05-12
    End date: 2011-05-25

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-06-01

Prednisolone
    Dosage: 10 milligram
    Indication: Multiple Myeloma
    Start date: 2012-02-09
    End date: 2012-02-17

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-03-31
    End date: 2011-04-13

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-03-30

Prednisolone
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2012-02-08

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-04-13

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2011-09-06

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-09-14
    End date: 2011-10-03

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-10-12
    End date: 2011-10-22

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-12-11
    End date: 2011-12-31

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2012-01-25
    End date: 2012-02-11

Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa



Possible Dexamethasone side effects in

Reported by a physician from France on 2012-07-18

Patient:

Reactions: Respiratory Tract Infection Fungal, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-06

Doxorubicin HCL
    Dosage: 15 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-06

Rituximab
    Dosage: 857 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-03

Velcade
    Dosage: 2 mg, unk
    Indication: Mantle Cell Lymphoma
    Start date: 2008-11-03
    End date: 2008-11-03



Possible Dexamethasone side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from Austria on 2012-07-18

Patient: 68 year old female, weighing 75.0 kg (165.0 pounds)

Reactions: Ventricular Arrhythmia, Pyrexia, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Carfilzomib
    Dosage: 50 milligram
    Start date: 2011-08-16
    End date: 2011-08-17

Carfilzomib
    Dosage: 49.7 milligram
    Start date: 2011-09-06
    End date: 2011-09-07

Carfilzomib
    Dosage: 49.7 milligram
    Start date: 2011-08-23
    End date: 2011-08-24

Carfilzomib
    Dosage: 36 milligram
    Indication: Multiple Myeloma
    Start date: 2011-08-09
    End date: 2011-08-10

Carfilzomib
    Dosage: 49.7 milligram
    Start date: 2011-09-13
    End date: 2011-09-14

Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2011-08-09
    End date: 2011-08-30

Dexamethasone
    Start date: 2011-09-06

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-08-09
    End date: 2011-08-29

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2011-09-08
    End date: 2011-09-12

Other drugs received by patient: Ciprofloxacin HCL; Iterium; Pamitor; Pantoprazole Sodium; Lasix; Nebilan; Simvastatin; Glandomed; Calcitonin Salmon; Mycostatin; Urosin; Marcumar; Marcumar; Valtrex; Augmentin '500'



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014